Mits Healthcare’s initial public offering marks a pivotal step in the company’s long-term growth strategy, with expansion and capacity enhancement at the core of its plans. The pharmaceutical manufacturer aims to leverage fresh capital to scale operations, strengthen its product portfolio, and widen its market reach in both domestic and export markets. The IPO comes at a time when demand for affordable and quality healthcare products is rising steadily.